Although there is currently no cure for this disease, there are currently mesothelioma clinical trials underway to test new drugs and procedures in the fight against the disease. These studies are divided into different phases.
In the first phase of mesothelioma clinical trials, only a small number of people are enrolled to test new drugs or decide how they should be administered. In the second phase, information is obtained about whether or not a new drug or procedure works, as well as information about safety and benefits.
In the third phase of mesothelioma clinical trials, promising new drugs or procedures are compared with current standard treatments. It is likely that larger numbers of people from across the nation will be involved, receiving either the new or the standard treatment to see which is the most effective.
So that the study results are sure to be accurate, participants in mesothelioma clinical trials must fit a certain profile. Eligibility is often specific according to age, the length of time since previous therapy, how far advanced the disease is, and other similar variables.
The National Cancer Institute has said the reason behind most mesothelioma clinical trials is to test new cancer treatments or new methods of diagnosing, screening for or preventing cancer. Because potentially harmful side effects are not know at the outset, dose and schedule modifications may necessary as the tests progress.
New kinds of drugs and treatments are constantly being tested to ensure that these patients receive the very best treatment that medicine today is able to provide in their particular circumstances.
More Related Information In Video/Audio Format:
No comments:
Post a Comment